CTVA
Corteva
$76.89
▲ 0.0%Updated Aug 7, 11:30 AM ET
CTVA at a glance — five pillars scored 0–100 from real filed financials.
Overall: Weak · 39/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 6.0% over the last 12 months
Market Cap
$57.38B
P/E
43.59x
Forward P/E (est.)
41.98x
ROE
4.7%
Revenue Growth
6.3%
EPS Growth
3.8%
Profit Margin
6.5%
FCF Yield
4.3%
Debt / Equity
0.11x
ROIC
—
Interest Coverage
—
Current Ratio
1.47x
Dividend Yield
1.0%
Implied Growth (rev. DCF)
3.9%
Rating Score
39/100
Corteva (CTVA) is a large-cap company in the Fertilizers & Agricultural Chemicals industry, part of the Materials sector of the S&P 500, with a market value around $57.38B.
In its latest reported year it generated about $17.40B in revenue and $1.09B in net profit.
Our model rates CTVA Weak (39/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CTVA's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CTVA trades near $76.89, around its 50-day average ($79.75) and 200-day average ($73.21). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 89 it is overbought — the recent rally is stretched and can cool off.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. CTVA's is $2.04 (~2.7% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month CTVA found buyers near $74.42 (support) and sellers near $85.95 (resistance); its 52-week range is $60.53–$85.95. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.7× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
2.7%
Revenue moved from $14.29B in 2018 to $17.40B in 2025, a 2.9% compound annual growth rate. The most recent year grew a steady 6.3% year over year. Slower, mature growth is common for established businesses.
Gross Margin
48.6%
Operating Margin
15.0%
Net Margin
6.3%
ROE
4.7%
Corteva keeps about 6.5% of each sales dollar as net profit, with a 48.6% gross margin and 15.0% operating margin. Return on equity is 4.7%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$791.00M
Net Debt
-$1.17B
Net cash position
Net Debt / EBITDA
—
Debt / Equity
0.11x
Leverage: debt-to-equity is 0.1x, with a current ratio of 1.5x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $791.00M of total debt against $1.96B of cash.
Operating CF
$3.41B
Free Cash Flow
$2.81B
FCF Margin
16.2%
In the latest year Corteva produced about $3.41B of operating cash flow and $2.81B of free cash flow after capital spending. That is a free-cash-flow yield of about 4.3% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The payout is comfortably covered by cash the business actually generates, with a raise habit behind it.
Dividend yield
1.0%
Per share (latest FY)
$0.70
Total paid (latest FY)
$475.00M
History on record
5 years
dividend uses 17% of free cash flow
43% of net income paid out
total dividends increased 4 years in a row
no cuts in the last 5 years on record
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
43.59x
P/S
2.91x
P/B
1.88x
EV / EBITDA
—
CTVA trades at 43.6x trailing earnings (about 42.0x on estimated forward earnings), 2.9x sales, and 1.9x book value. Reverse-engineering today's price implies the market expects roughly 3.9% long-term free-cash-flow growth. That is a rich multiple that prices in a lot of future growth.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$82.13
Current price
$76.89
Starting FCF (latest 10-K)
$2.81B
Growth, years 1–5
6.3%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where CTVA sits versus its Materials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 54 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How CTVA stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (78 S&P 500 companies), CTVA ranks #43 of 78 by our overall rating. It trades at a premium versus the sector on earnings (43.6x P/E vs. 22.7x median) with a lower return on equity (4.7% vs. 16.1%) and slower revenue growth (6.3% vs. 7.9%).
P/E vs sector
43.6x
median 22.7x
ROE vs sector
4.7%
median 16.1%
Growth vs sector
6.3%
median 7.9%
Sector rank
#43
of 78 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 78 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $76.89 today · expected CAGR -9% – 1%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $18.45B | $19.55B | $20.72B | $21.97B | $23.29B |
| Net income | $1.11B | $1.17B | $1.24B | $1.32B | $1.40B |
| EPS | $1.48 | $1.57 | $1.67 | $1.77 | $1.87 |
| Share price (low) | $38.55 | $40.87 | $43.32 | $45.92 | $48.67 |
| Share price (high) | $65.25 | $69.16 | $73.31 | $77.71 | $82.37 |
| CAGR (low–high) | -50% / -15% | -27% / -5% | -17% / -2% | -12% / 0% | -9% / 1% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for CTVA:
- Healthy free-cash-flow yield (~4.3%) funds buybacks and dividends.
- A conservative balance sheet (debt/equity 0.1x) lowers risk.
The case against CTVA:
- A rich 43.6x earnings multiple prices in a lot of growth.
- Our model's overall read is Weak (39/100).
Valuation risk — at 43.6x earnings, disappointing results could compress the multiple.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Corteva is a large-cap materials business growing at a mature pace, with modest profitability, and a sound balance sheet. It trades at 43.6x earnings, which our model scores Weak (39/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 29 Wall Street analysts covering CTVA recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more cautious over the last three months (-4 pts of buy ratings).
Latest SEC Filings
CTVA's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
CTVA — frequently asked questions
Is CTVA a good stock to buy?
We don't give buy or sell advice. Our model rates Corteva Weak (39/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is CTVA's rating on The Stocks School?
Corteva currently scores 39/100 (Weak) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does CTVA's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Corteva's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for CTVA calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this CTVA analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CTVA. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.